Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SSTR4 | P31391 | 2/20 | 0.34 |
| ▸ | NAAA | Q02083 | 2/20 | 0.33 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.33 |
| ▸ | EPHX1 | P07099 | 3/20 | 0.33 |
| ▸ | CHRM2 | P08172 | 6/20 | 0.32 |
| ▸ | CHRM4 | P08173 | 6/20 | 0.32 |
| ▸ | CHRM1 | P11229 | 6/20 | 0.32 |
| ▸ | CHRM3 | P20309 | 6/20 | 0.32 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.31 |
| ▸ | HTT | P42858 | 1/20 | 0.31 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.31 |
| ▸ | FKBP1A | P62942 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19982412 | 0.98 | CHRM2 (0.32) | SSTR4NAAAEPHX2EPHX1CHRM2 | |
| SCHEMBL12811979 | 0.85 | SSTR4 (0.32) | SSTR4NAAAEPHX2EPHX1CHRM2 | |
| SCHEMBL9609262 | 0.84 | LMNA (0.36) | SSTR4NAAAEPHX2EPHX1CHRM2 | |
| SCHEMBL19558199 | 0.81 | SSTR4 (0.36) | SSTR4NAAAEPHX2EPHX1CHRM2 | |
| SCHEMBL118416 | 0.81 | SSTR4 (0.36) | SSTR4NAAAEPHX2EPHX1CHRM2 | |
| SCHEMBL26353243 | 0.81 | SSTR4 (0.36) | SSTR4NAAAEPHX2EPHX1CHRM2 | |
| SCHEMBL26353589 | 0.81 | SSTR4 (0.36) | SSTR4NAAAEPHX2EPHX1CHRM2 | |
| SCHEMBL9609264 | 0.81 | LMNA (0.37) | EPHX1CHRM2CHRM4CHRM1CHRM3 | |
| SCHEMBL31465107 | 0.81 | LMNA (0.42) | NAAAEPHX1CHRM2CHRM4CHRM1 | |
| SCHEMBL24371964 | 0.81 | SSTR4 (0.30) | SSTR4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10234759-B2 | Actinic-ray- or radiation-sensitive resin composition, actinic-ray- or radiation-sensitive film and method of forming pattern | FUJIFILM CORPORATION (JP) | 2019-03-19 | — | — | US | disclosed |
| WO-2013047396-A1 | PATTERN FORMING METHOD, ELECTRON BEAM-SENSITIVE OR EXTREME ULTRAVIOLET-SENSITIVE COMPOSITION, RESIST FILM, METHOD FOR MANUFACTURING ELECTRONIC DEVICE USING THE SAME, AND ELECTRONIC DEVICE | FUJIFILM CORPORATION (JP) | 2013-04-04 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10234759-B2 | Actinic-ray- or radiation-sensitive resin composition, actinic-ray- or radiation-sensitive film and method of forming pattern | AFF1, MACF1, RER1 | SSTR4 2408/4885NAAA 3461/4885EPHX2 1435/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.